Daniel Kazado serves as Executive at IMMUNE PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Daniel Kazado has executed 7 insider transactions totaling $555.7K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jan 4, 2017 involved purchasing 76,503 shares valued at $14.5K.
Daniel Kazado currently holds 1,145,171 shares of IMMUNE PHARMACEUTICALS INC (IMNP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Daniel Kazado has been a net buyer of IMNP stock. They have purchased $555.7K and sold $0 worth of shares.
Daniel Kazado's most recent insider trade was on Jan 4, 2017, when they purchased 76,503 shares at $0.19 per share.
Get notified when new Form 4 filings are submitted
| $0.19 |
| Discretionary |
| Aug 4, 2016 | IMNP | $300.0K | Purchase | 666,667 | $0.45 | Discretionary |
| Dec 7, 2015 | IMNP | $117.0K | Purchase | 150,000 | $0.78 | Discretionary |
| Sep 14, 2015 | IMNP | $73.5K | Purchase | 50,000 | $1.47 | Discretionary |
| Jul 15, 2015 | IMNP | $22.1K | Conversion | 14,656 | $1.51 | Discretionary |
| Nov 26, 2014 | IMNP | $20.0K | Purchase | 8,000 | $2.50 | Discretionary |